Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERICA antiemetic prophylaxis study with or without olanzapine during T-DXd treatment
jRCTs031210410Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of olanzapine in Nausea and Vomiting (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Started Nov 2021; status: completed.
02
Drugs
olanzapine
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on jRCTs031210410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210410.